ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2015 American Transplant Congress

    Distinct Subtypes of Rejection in a Novel Non Human Primate Model of Sensitization

    C. Burghuber,1,2 J. Kwun,1,3 F. Leopardi,3 A. Gibby,1 A. Farris,1 N. Iwakoshi,1 S. Knechtle.1,3

    1Emory University, Atlanta, GA; 2Medical University Vienna, Vienna, Austria; 3Duke University, Durham, NC.

    [Background] Preformed and newly formed alloantibody post transplantation (TX) can significantly deteriorate graft survival. Patterns of humoral rejection in sensitized patients varies significantly due to…
  • 2015 American Transplant Congress

    Differentially Expressed IL-6Rα and GP130 Genes in Kidney Biopsies (Bxs) Suggests Different Roles of IL-6 Signaling in Antibody (ABMR)- and Cell (CMR)-Mediated Rejection

    H. Zhang,1 D. Thomas,1 J. Kowalewska,2 E. Suviolahti,1 H. Shafi,2 C. Nast,2 A. Gertych,2 A. Vo,1 M. Haas,2 S. Jordan,1 M. Toyoda.1

    1Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA; 2Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background: IL-6 exerts immunoregulatory properties through IL-6 receptors, IL-6Rα and gp130. Our previous studies suggested the involvement of antibody-dependent cellular cytotoxicity (ADCC) and its related…
  • 2015 American Transplant Congress

    Neogenin Functions as a Chemokinetic Receptor on Activated CD4+ T Lymphocytes

    L. Boneschansker,1 H. Nakayama,1 M. Eisenga,1 M. Klagsbrun,1 D. Irimia,2 D. Briscoe.1

    1Boston Children's Hospital, Boston; 2Massachusetts General Hospital, Boston.

    Increasing data indicates that axonal guidance cues play a critical role in immunity, both in activation, migration as well as in the process of inflammation…
  • 2015 American Transplant Congress

    A Prospective Study of Renal Function and Histological Changes in Renal Transplant Recipients With Acute Clinical and Subclinical Rejection

    S. Chen,1 R. Mehta,1 P. Sood,1 P. Randhawa,2 N. Shah,1 C. Wu,1 A. Tevar,3 S. Hariharan.1

    1Nephrology, University of Pittsburgh Medical Center, Pittsburgh, PA; 2Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA; 3Transplant Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

    Background: To study the impact on renal function and histological changes in patients(pts) with acute clinical rejection(ACR) and subclinical rejection(SCR) from 3 to 12 month(m)…
  • 2015 American Transplant Congress

    Renal Outcomes of Cross Match Positive Simultaneous Liver Kidney (SLK) Transplant Recipients Compared to Cross Match Positive Kidney Allograft Recipients

    S. Vaishnav,1 T. Taber,1 W. Goggins,2 S. Nagaraju,2 J. Fridell,2 A. Sharfuddin,1 M. Yaqub,1 D. Mishler,1 M. Mujtaba.1

    1IUSM, IU Health, Indianapolis, IN; 2Surgery, Transplant, Indiana University School of Medicine, Indianapolis, IN.

    The protective role of liver in cross-match(XM) positive SLK recipients and its impact on the incidence of renal antibody mediated rejection (AMR) is unclear.A retrospective…
  • 2015 American Transplant Congress

    Pretransplant Antibodies Against Angiotensin II Type 1 Receptor in Renal Transplantation: Preliminary Data from the KNOW-KT Study

    K. Huh,1 J. Lee,1 Y. Park,2 Y. Kim,1 C. Ahn.3

    1Department of Transplantation Surgery, Yonsei University Health System, Seoul, Republic of Korea; 2Department of Laboratory Medicine, Yonsei University Health System, Seoul, Republic of Korea; 3Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

    BackgroundThe antibodies (Abs) against angiotensin II type 1 receptor (AT1R) have been suggested as a risk factor for graft failure and acute rejection. However, incidence…
  • 2015 American Transplant Congress

    Thymoglobulin Versus IL2RA: Three Year Results of a Randomized Controlled Trial

    N. Pilch, H. Meadows, D. Taber, J. Fleming, C. Mardis, S. Nadig, J. McGillicuddy, T. Srinivas, C. Bratton, P. Baliga, K. Chavin.

    Transplant, MUSC, Charleston, SC.

    This is a three year follow-up of a prospective, randomized controlled trial (RCT) to determine the safety and efficacy of induction with rabbit antithymocyte globulin…
  • 2015 American Transplant Congress

    Constitutively Upregulated Expression of Complement and Matrix Transcripts in Kidney Transplant Recipients Who Develop Acute Rejection

    K. Keslar,1 J. Reid-Adam,4 E. Kwon,4 D. Hricik,5 E. Poggio,2,3 P. Heeger,4 R. Fairchild.1,3

    1Immunology, Cleveland Clinic; 2Nephrology, Cleveland Clinic; 3Glickman Urological Institute and Transplant Center, Cleveland Clinic, Cleveland, OH; 4Icahn School of Medicine, Mount Sinai, New York, NY; 5Nephrology, UH Case Medical Center, Cleveland, OH.

    Identification of kidney transplants at elevated risk of acute rejection (AR) and/or chronic injury prior to loss of kidney function (GFR) could guide therapies to…
  • 2015 American Transplant Congress

    Clinicopathological Scenarios (CPS) Defined by Viremia, Creatinine and Histology in Polyomavirus Nephropathy Differ in 1st and 2nd (Follow-Up) Biopsy

    C. Drachenberg, M. Chaudhry, F. Yang, R. Ugarte, A. Haririan, M. Mavanur, C. Cangro, B. Thomas, N. Costa, E. Ramos, M. Weir, J. Papadimitriou.

    Pathology and Medicine, University of Maryland School of Medicine, Baltimore, MD.

    Studies of sequential kidney biopsies (KB) after the diagnosis of polyomavirus allograft nephropathy (PVN) are scarce and clinicopathological evolution of PVN poorly understood. In practice…
  • 2015 American Transplant Congress

    Impact of HLA Antibody Monitoring After Kidney Transplantation

    S. Rao,1 M. Ghanta,1 H. Parekh,2 A. Gillespie,1 I. Lee,1 S. Geier,2 K. Lau,3 S. Karhadkar,3 A. Di Carlo,3 S. Constantinescu.1

    1Nephrology, Temple Univesity School of Medicine, Philadelphia, PA; 2Pathology, Temple Univesity School of Medicine, Philadelphia, PA; 3Surgery, Temple Univesity School of Medicine, Philadelphia, PA.

    The impact of donor specific antibodies (DSA) and optimal therapeutic intervention for DSA in kidney transplant (KT) recipients has been reported with variable results. We…
  • « Previous Page
  • 1
  • …
  • 163
  • 164
  • 165
  • 166
  • 167
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences